Citation Impact
Citing Papers
Colorimetric protein assay techniques
1999
Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans
2013 Standout
Diabetic and Galactosaemic Cataracts
1984
Quercetin inhibits hydrogen peroxide-induced oxidation of the rat lens
1999
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
2003 Standout
Monitoring cyclodextrin–polyviologen pseudopolyrotaxanes with the Bradford assay
2005 StandoutNobel
Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis
1999
Pathophysiology of Progressive Nephropathies
1998 Standout
Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations
2007 Standout
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
2000 StandoutNature
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
2008 Standout
Distribution and Biological Activities of the Flavonoid Luteolin
2008 Standout
Aldose reductase inhibitors and their potential for the treatment of diabetic complications
1994
Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice
1992
New approaches for treatment in diabetes: Aldose reductase inhibitors
1995
Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor
1997
Regulation of Cell Volume in Health and Disease
1995
Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450
2002 Standout
Increased NADH Oxidase Activity in the Retina of the BBZ/WOR Diabetic Rat
1998
Vitamin E Intake and Risk of Cataracts in Humansa
1989
Diabetes, oxidative stress, and antioxidants: A review
2003 Standout
Vascular endothelial growth factor in eye disease
2008 Standout
Partners in transcription: NFAT and AP-1
2001 Standout
Long-Term Complications of Diabetes Mellitus
1993 Standout
Pathophysiology and pharmacologic treatment of acute spinal cord injury*1
2004 Standout
The role of aldose reductase in the development of diabetic complications
1988
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Traumatic spinal cord injury
2017 Standout
Effects on rat renal osmolytes of extended treatment with an aldose reductase inhibitor
1992
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Hypernatremia
2000 Standout
Epidemiology, Demographics, and Pathophysiology of Acute Spinal Cord Injury
2001 Standout
Ultrahigh resolution drug design I: Details of interactions in human aldose reductase–inhibitor complex at 0.66 Å
2004 Standout
A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury
1990 Standout
Mechanisms of diabetic hyperfiltration
1991
Role of aldose reductase and sorbitol in maintaining the medullary intracellular milieu
1988
The role of polyols in the pathophysiology of hypergalactosemia
1995
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
1988 Standout
Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/WOR diabetic rat
2000
Localization of aldose and aldehyde reductase in the kidney
1989
Hypertonic Induction of Aquaporin-5 Expression through an ERK-dependent Pathway
2000 StandoutNobel
Administration of Ascorbic Acid and an Aldose Reductase Inhibitor (Tolrestat) in Diabetes: Effect on Urinary Albumin Excretion
1998
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Medical management of nephropathy in type I diabetes mellitus
1995
Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.
1995
Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus
2010
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
2016 Standout
Aldose Reductase and Advanced Glycation Endproducts Inhibitory Effect of Phyllostachys nigra
2007
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic Complications
1987 Standout
Oxidative Stress and Diabetic Complications
2010 Standout
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Characterization of the osmotic response element of the human aldose reductase gene promoter.
1996
Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications.
1992
Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
1999
Binding of an aldose reductase inhibitor to renal glomeruli
1985
Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM Subjects With Nephropathy
1993
Aldose reductase inhibitors: therapeutic implications for diabetic complications
1999
Studies and Perspectives of Protein Kinase C
1986 StandoutScience
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
1999 Standout
Mechanisms of Diabetic Complications
2013 Standout
Protein Kinase C Agonists Acutely Normalize Decreased Ouabain-inhibitable Respiration in Diabetic Rabbit Nerve: Implications for (Na,K)-ATPase Regulation and Diabetic Complications
1986
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 Standout
Aldose reductase mRNA expression and its activity are induced by glucose in fetal rat aortic smooth muscle (A10) cells
1992
Glucocorticoid mechanisms in acute spinal cord injury: A review and therapeutic rationale
1982
Two New Stereoisomers of Neolignan and Lignan from the Flower Buds of <i>Magnolia fargesii</i>
2009
Computer Simulation Studies of the Catalytic Mechanism of Human Aldose Reductase
2000 StandoutNobel
Aldose Reductase and Cardiovascular Diseases, Creating Human-Like Diabetic Complications in an Experimental Model
2010
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
REGULATION OF GENE EXPRESSION BY HYPERTONICITY
1997
Metformin reduces systemic methylglyoxal levels in type 2 diabetes.
1999 Standout
Inhibitory Effects of Isorhamnetin-3-O-.BETA.-D-glucoside from Salicornia herbacea on Rat Lens Aldose Reductase and Sorbitol Accumulation in Streptozotocin-Induced Diabetic Rat Tissues
2005
Works of A. Beyer‐Mears being referenced
The polyol pathway, sorbinil, and renal dysfunction
1986
Comparison of the Effects of Zopolrestat and Sorbinil on Lens Myo lnositol Influx
1997
Reversal of Proteinuria by Sorbinil, an Aldose Reductase Inhibitor in Spontaneously Diabetic (BB) Rats
1988
ASSESSMENT OF PROTEINURIA AND NEUROPATHY IN THE NONIMMUNOSUPPRESSED BB DIABETIC RAT AFTER ABDOMINAL INTRATESTICULAR ISLET TRANSPLANTATION
1993
Zopolrestat Prevention of Proteinuria, Albuminuria and Cataractogenesis in Diabetes mellitus
1996
A mechanism for regulatory volume decrease in cultured lens epithelial cells
1997
Myo-inositol transport in the lens of galactose-maintained rats
1992
Comparison of Sorbinil and Ponalrestat (Statil) Diminution of Proteinuria in the BB Rat
1992
Dietary Myo-Inositol Effect on Sugar Cataractogenesis
1989
Reversal of Stage-I Sugar Cataract by Sorbinil, an Aldose Reductase Inhibitor
1985
Sorbinil Protection of Lens Protein Components and Cell Hydration during Diabetic Cataract Formation
1982
Reversal of Diabetic Cataract by Sorbinil, an Aldose Reductase Inhibitor
1985
Mechanisms for D -Glucose Inhibition of myo-Inositol Influx Into Rat Lens
1993
Diminished Proteinuria in Diabetes mellitus by Sorbinil, an Aldose Reductase Inhibitor
1986
Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil
1984
Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor
1985
Glomerular Polyol Accumulation in Diabetes and its Prevention by Oral Sorbinil
1984
Synergism of Sorbinil and Normal Diet on Reversal of Stage-II Sugar Cataract
1985
Dexamethasone preservation of motor function in phospholipase A2-induced caudate lesions
1980
Diminished sugar cataractogenesis by quercetin
1979